Boan Biotech’s Dulaglutide Injection (BA5101) Approved for Clinical Trials in China

For glycemic control in adult patients with type 2 diabetes.

Boan Biotech to Present the Pre-clinical Data of Its Proprietary CD3+ T-cell Engager Platf...

Luye Pharma’s Rivastigmine Multi-Day Transdermal Patch Receives Marketing Approval in the...

For the treatment of mild to moderate dementia associated with Alzheimer’s disease

Luye Pharma’s Goserelin Microsphere Formulation Meets Preset Endpoints in Phase III Clini...

New Indication for Boan Biotech’s Boyounuo (Bevacizumab Injection) Approved in China

Treatment of Recurrent Glioblastoma

The Third Asia Pacific Psychiatry Symposium Takes Place

Over One Thousand Psychiatrists Gather to Discuss the Diagnosis and Treatment of Mental Disorders During COVID...